Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23257433 | 0.94 | ADM2 (1.00) | ADM2CALCB | |
| SCHEMBL29814027 | 0.94 | ADM2 (1.00) | ADM2CALCB | |
| SCHEMBL23257100 | 0.93 | ADM2 (0.97) | ADM2CALCB | |
| SCHEMBL29813988 | 0.90 | ADM2 (0.85) | ADM2CALCB | |
| SCHEMBL29814104 | 0.90 | ADM2 (0.80) | ADM2CALCB | |
| SCHEMBL23257395 | 0.90 | ADM2 (0.80) | ADM2CALCB | |
| SCHEMBL23257374 | 0.90 | ADM2 (0.85) | ADM2CALCB | |
| SCHEMBL23257443 | 0.90 | ADM2 (0.89) | ADM2CALCB | |
| SCHEMBL23257606 | 0.90 | ADM2 (0.83) | ADM2CALCB | |
| SCHEMBL29813694 | 0.90 | ADM2 (0.83) | ADM2CALCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3628045-B1 | COMPOUNDS | UNIV SHEFFIELD (GB) | 2024-07-03 | — | — | EP | disclosed |
| US-20210113534-A1 | COMPOUNDS | THE UNIVERSITY OF SHEFFIELD (GB) | 2021-04-22 | — | — | US | disclosed |
| CN-110891951-A | Compound (I) | 谢菲尔德大学 | 2020-03-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210113534-A1 | COMPOUNDS | MRGPRX2, MC2R, ADM2 | ADM2 3/4885CALCB 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.